A
Assem Barakat
Researcher at King Saud University
Publications - 260
Citations - 2771
Assem Barakat is an academic researcher from King Saud University. The author has contributed to research in topics: Chemistry & Crystal structure. The author has an hindex of 24, co-authored 207 publications receiving 1979 citations. Previous affiliations of Assem Barakat include Damietta University & Mansoura University.
Papers
More filters
Journal ArticleDOI
The asymmetric aza-Claisen rearrangement: development of widely applicable pentaphenylferrocenyl palladacycle catalysts.
Daniel F. Fischer,Assem Barakat,Assem Barakat,Zhuo‐qun Xin,Zhuo‐qun Xin,Matthias E. Weiss,René Peters +6 more
TL;DR: Results suggest that face-selective olefin coordination is the enantioselectivity-determining step, which is almost exclusively controlled by the element of planar chirality in the asymmetric aza-Claisen rearrangements.
Journal ArticleDOI
One step synthesis of NiO nanoparticles via solid-state thermal decomposition at low-temperature of novel aqua(2,9-dimethyl-1,10-phenanthroline)NiCl2 complex.
Assem Barakat,Mousa Al-Noaimi,Mohammed Suleiman,Abdullah S. Aldwayyan,Belkheir Hammouti,Taibi Ben Hadda,Salim F. Haddad,Ahmed Boshaala,Ismail Warad +8 more
TL;DR: The desired complex, subjected to thermal decomposition at low temperature of 400 ºC in an open atmosphere, revealed a novel and facile synthesis of pure NiO nanoparticles with uniform spherical particle.
Journal ArticleDOI
Synthesis, reactions and biological activity of some new bis-heterocyclic ring compounds containing sulphur atom
Yahia N. Mabkhot,Assem Barakat,Assem Barakat,Abdullah Mohammed Al-Majid,Saeed Alshahrani,Sammer Yousuf,M. Iqbal Choudhary,M. Iqbal Choudhary +7 more
TL;DR: These new derivatives of thieno[2,3-b]thiophene belong to a significant category of heterocyclic compounds, which have shown a wide spectrum of medical and industrial application and were evaluated for anti-cancer activity against PC-3 cell lines, in vitro antioxidant potential and β-glucuronidase and α- glucosidase inhibitory activities.
Journal ArticleDOI
Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.
Mohammad Shahidul Islam,Hussien Mansur Ghawas,Fardous F. El-Senduny,Abdullah Mohammed Al-Majid,Yaseen A.M.M. Elshaier,Farid A. Badria,Assem Barakat,Assem Barakat +7 more
TL;DR: Compound 4k proved to retain a high cytotoxic activity and selectivity against colon cancer cells HCT-116, hepatocellular carcinoma, and prostate cancer cells PC-3 in comparison to cisplatin, and ligand Efficiency and Ligand Lipophilic Efficiency were evaluated and revealed that compound 4k had acceptable value.
Journal ArticleDOI
Synthesis of new spirooxindole-pyrrolothiazole derivatives: Anti-cancer activity and molecular docking.
Gehad Lotfy,Mohamed M. Said,El Sayed H. El Ashry,El Sayed H. El Tamany,Abdullah Al-Dhfyan,Yasmine M. Abdel Aziz,Assem Barakat +6 more
TL;DR: The 1,3-dipolar cycloadditions of an azomethine ylide generated from isatin and thiazolidinecarboxylic acid to a series of 2,6-bis[(E)-arylmethylidene]cyclohexanones afforded new di-spiro heterocycles incorporating pyrrolidine and oxindole rings in quantitative yields and chemo- regio- and stereoselectively.